A multi-institutional study investigates RAS, RAF, and MAPK alterations in prostatic adenocarcinoma, providing insights into potential therapeutic targets. The findings may influence future research and treatment strategies for this cancer type.
ras raf mapk alterations in prostatic adenocarcinoma a multi institutional study
Original title: “RAS/RAF/MAPK Alterations in Prostatic Adenocarcinoma: A Multi-Institutional Study.”